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Abstract
Background:  CT-Scan is currently under assessment for the screening of asbestos-related
diseases. However, to date no consensus exists as to how to select high-risk asbestos-exposed
populations suitable for such screening programs. The objective of this study is to select the most
relevant exposure variables for the prediction of pleural plaques and asbestosis in order to guide
clinicians in their use of CT-Scan.
Methods:  A screening program of non malignant asbestos-related diseases by CT-scan was
conducted among asbestos-exposed volunteers in France. Precise assessments of asbestos
exposure were obtained by occupational hygiene measurements and a job-exposure matrix.
Several parameters were calculated (time since first exposure, duration, intensity and cumulative
exposure to asbestos). Predictive parameters of prevalence and incidence were then estimated by
standard logistic and a complementary log-log regression models.
Results:  1011 subjects were recruited in this screening program among them 474 (46.9%)
presented with pleural plaques and 61 (6.0%) with interstitial changes compatible with asbestosis
on CT-scan. Time since first exposure (p < 0.0001) and either cumulative or mean exposure (p <
0.0001) showed independent associations with both pleural plaques and asbestosis prevalence and
pleural plaques incidence. Modelling incidence of pleural plaques showed a 0.8% to 2.4% yearly
increase for a mean exposure of 1 f/ml.
Conclusion: Our findings confirmed the role played by time since first exposure and dose but not
duration in asbestos-related diseases. We recommend to include these parameters in high-risk
populations suitable for screening of these diseases. Short-periodicity of survey of pleural plaques
by CT-Scan seemed not to be warranted.
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Background
CT-scan is without contest the reference tool for diagnosis
of asbestos-related diseases as this technique is both more
sensitive and more specific than chest X-rays [1]. An inter-
national consensus conference [2] has recommended the
use of CT-scan in exposed population for clinical individ-
ual evaluation or research purposes with respect to pleural
plaques and asbestosis. Several countries, who develop
thoughts about specific compensation funds for non
malignant asbestos related diseases such as the American
Senate or the French Law, recommend the use of CT-scan
for the diagnosis of such diseases. The prevalence of both
pleural plaques and asbestosis is associated with time
since first exposure to asbestos, intensity level, duration or
cumulative exposure to asbestos depending on the studies
[1,3,4], but these criteria remain entangled. Moreover, the
majority of these published studies are based on chest X-
ray data, resulting in difficulties and imprecision for the
estimation of dose-response relationships for asbestos-
related diseases. Thus in the few papers predicting the
prevalence and incidence of pleural plaques [5] or asbes-
tosis [6], none used CT-scan data and the shape of the
dose-response relationships remains uncertain [7]. As a
result, Begin et al. underlines that CT-Scan is not yet a
"gold-Standard" despite his higher sensitivity relative to
CXR because of absence of clearly established exposure-
response relationships [8]
Recommendations for potential applications of CT scan
in lung cancer screening among asbestos exposed subjects
have also been reported [4]. Among these statements, the
need to assess the respective role of known risk factors of
lung cancer (latency and cumulative exposure to asbestos,
smoking characteristics, age, asbestos related radiographic
findings) was highlighted in order to define populations
suitable for such screening programs. Since then several
authors [9-11] have recently proposed CT-scan lung can-
cer screening programs in exposed to asbestos popula-
tions with empiric definition of "high risk" group.
Accordingly, a widespread CT-Scan screening of occupa-
tionally asbestos-exposed populations could become a
major public health option, only if it is possible to define
reliably high-risk groups.
The present paper presents the results of a modelling
based on a large population with detailed asbestos expo-
sure information and systematic CT-scans. The aim was to
determine which exposure parameters are most useful to
the clinicians in the selection of asbestos-exposed subjects
to be submitted to a CT-Scan as part of a screening exer-
cise.
Population and methods
Eligibility criteria
A screening program for asbestos-related diseases was
instated in 1991 in Normandy (France). We included in
this study volunteers subjects over 50 years, including reti-
rees whatever their ages, from specific plants well known
to have past heavy use of asbestos, mainly asbestos textile
and friction materials fabrication, insulation and energy
production The program began by the most exposed
workers (as a result the older ones), and was then progres-
sively extended to the more recently exposed subjects.
Detailed methods and preliminary reports were previ-
ously published [12,13] concerning this program.
All subjects had to be free of previous involvement in sys-
tematic HRCT screening campaigns in their companies,
and had to be not known to carry asbestos-related diseases
prior to the time of inclusion. Retired subjects were
recruited either by mail from their former employers or
through local information meetings. Active workers were
informed by their occupational physicians. All included
subjects gave their written informed consent. All investi-
gations were performed in four hospitals located in
Rouen, Le Havre, Caen and Flers.
Clinical and Occupational data
All subjects underwent a standard interview in order to
obtain occupational, medical and smoking histories. For
occupations implying asbestos exposure in one or several
companies, dates of hire and end of assignments as well
as durations of exposure were recorded. For some subjects
who had worked in an asbestos textile and friction mate-
rial plant, a quantitative assessment of occupational expo-
sure was obtained using a specific Job Exposure Matrix
(JEM) elaborated from airborne measurements collected
annually between 1959 and 1999 in the various work-
shops of the plant. For all other subjects, estimation of
asbestos-exposure level associated with each job was
assessed using published airborne measurements availa-
ble in the French Database Evalutil [14] according to the
calendar period of exposure and the reported usual tasks.
For all subjects, a cumulative exposure index (CEI) was
then calculated and was expressed in fibers/ml.years. It
was obtained by summing over all job positions held,
with reference to the occupational calendar established in
the interview, products of typical job exposure level (in
fibers/ml) by job duration (in years). An average exposure
index was calculated by dividing the CEI by the duration
of exposure. Time since first exposure to asbestos, dura-
tion of exposure (years), cumulated exposure index and
the average exposure index were used in the statistical
analysis as asbestos exposures descriptors.Environmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
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Diagnosis of pleural plaques and asbestosis from imaging
Conditions of CT scan were previously described in detail
[13]. Briefly, all subjects underwent a conventional or spi-
ral CT-scan without contrast material depending on the
date of inclusion. In order to minimize difference
between the two generations of CT-Scan, only incremen-
tal CT-Scan with joined centimetric slices of complete tho-
rax were kept. However, in both cases, all examinations
included HRCT slices. The two generation of CT Scan dif-
fered by the number of HR slices as the first kind included
at least six high-resolution millimetric sections in prone
position and full inspiration, five of which were equally
spaced between the carina of trachea and the bottom part
of the costophrenic angles, whereas the remaining section
was half way between the carina of trachea and the
extreme pulmonary apices. For spiral CT-Scan, acquisi-
tions slices were conducted in prone position only if the
first sequence showed interstitial abnormalities.
Reading was carried out using a standard grid describing
the features of (a) asbestos-related pulmonary fibrosis
lesions (i.e., interlobular septal thickening, intralobular
lines, honeycombing, subpleural curvilinear lines and
ground-glass opacity), and (b) pleural fibrosis lesions
(i.e., pleural plaques and diffuse pleural thickening), as
well as (c) the pulmonary opacities associated with pleu-
ral changes (i.e., parenchymal bands and rounded atel-
ectasis), as described by several authors [15,16]. In
particular, pleural plaques were defined as discrete, dense,
pleural linear structures, which may have a smooth or
nodular inner surface, calcified or not, and with a width of
at least 2 mm. Interstitial changes compatible with asbes-
tosis was assessed from the HRCT interstitial abnormali-
ties that persisted in prone position. Radiological
abnormalities namely interstitial changes compatible
with asbestosis, pleural plaques and diffuse pleural thick-
ening, were independently rated (no, possible, certain) by
three readers from a five-reader panel who were blinded
to the subject's medical data and occupational character-
istics. The median of the three rates was retained as the
final rate. Only certain pleural plaques and interstitial
changes compatible with asbestosis were considered for
statistical analyses due to the small number of cases of
pleural diffuse thickening.
Statistical methods
The prevalence was analyzed using a standard logistic
model. Such a model fits a linear model on the logistic
transformation of the prevalence.
In mathematical terms, if we denote by P the prevalence,
the fitted model is:
exp(β1) (respectively exp(β2)) is the Odds Ratio by unit of
X1 (respectively X2), that is the number by which the dis-
ease odds is multiplied if exposure X1 (respectively X2)
increases by one unit. Different models are computed
with different exposure variables: time since first expo-
sure, total cumulative exposure, duration of exposure and
mean exposure, that is the total cumulative exposure
divided by the duration of exposure. The retained models
discard the variables which are non-significant once
adjusted on the others. The overall fit of the data was
assessed using the Akaike Information Criterion (AIC),
the better fit being indicated by higher values of the AIC.
From each of the selected model, a prediction of the pop-
ulation prevalence can be obtained for each given asbes-
tos values of the exposure variables.
A second analysis tries to infer the effect of the asbestos
exposure on the incidence of pleural plaques based on the
model developed by Järvholm [5] which we extend by
incorporating the quantitative exposure assessment
obtained in the present study. This model presupposes
that the probability of belonging to this study population
does not depend on the disease status (given the expo-
sure), and that the exposure has stopped at the time of
data collection. Assuming that the incidence is a power
function of a lagged time since first exposure multiplied
by a function of the exposure (either cumulative exposure
and/or mean exposure and/or duration of exposure or the
log transformed versions of these variables), it can be
identified from the prevalence data (see appendix). The
different (non-nested) models we compared using the
Akaike information criterion.
Results
Table 1 presents the age and smoking structure as well as
all collected variables with respect to the asbestos expo-
sure, according to the diagnosis of the CT-scan among the
1011 subjects included in this study. As expected, subjects
with pleural plaques or asbestosis are older than the
healthy population. We note that while the numbers of
never smokers are lower among the cases, the number of
pack years is similar in the three groups.
All asbestos exposure indices, except age at first exposure,
are larger when either pleural plaques or asbestosis have
been diagnosed. It is noteworthy that the differences in
time since first exposure correspond approximately to the
age differences between the groups.
Table 2 presents two alternative logistic models for the
prevalence of pleural plaques as a function respectively of
the mean asbestos exposure level and the cumulative
exposure. These models were obtained by successively
including all asbestos variables and several potential con-
log( () ) P
P XX 1 11 22 − =+ + αβ βEnvironmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
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founders (age, obesity, period of birth). None of the latter
confounding variables reached a 10% significance levels,
so that they were not entered in the model.
As indicated by the higher value of the AIC, the model
including TSFE and the mean asbestos exposure showed a
better fit than the model including TSFE and cumulative
exposure. It is notable that duration of exposure was not a
significant predictor of the prevalence of pleural plaques
after adjusting for TSFE. For subjects with identical expo-
sure levels and TSFE, the pleural plaques prevalence was
even slightly lower for subjects with longer duration of
exposure.
The models were also fitted within the two recruitment
subpopulations and to the subpopulation of all subjects
with a CEI less than 250 fibers/ml.years. All results were
compatible with the models presented in Table 2.
Model 1 predicts e.g. that the prevalence is multiplied by
1.075, or equivalently increases by 7.5%, with each year
after the onset of exposure. Figure 1 shows the predicted
evolution of the prevalence graphically for selected values
of the mean exposure.
When estimating an incidence, using a complementary
log-log regression, the models with the best fit included
linear exposure concentration and/or cumulative expo-
sure rather than log-transformed variables. As for the
logistic model the duration of exposure did not signifi-
cantly contribute to the fit and was dropped. With respect
to the minimum latency time, all models with a mini-
mum latency between 6 and 12 years yielded a virtually
identical fit.
Table 3 presents the fit of the complementary log-log
regression with a minimal latency of 10 years and its inter-
pretation as a model for the incidence of pleural plaques.
The parameters of the incidence curve can be interpreted
in terms of absolute and relative risks. E.g the yearly inci-
dence rate for 2 f/ml and 20 years since first exposure is
estimated at 0.00823 · 100.340 · exp(0.0690 · 2) = 2.1%.
Similarly according to model 1, the relative risk of a sub-
Table 1: Asbestos exposure and confounders among males according to disease status
Healthy subjects (n = 476) Pleural plaques (n = 474) Fibrosis (n = 61)
age 60.6 ±8.0 64.0 ±8.2 64.8 ±9.2
Non-smokers (n(%)) 156 32.8% 116 24.5% 18 23.1%
Ex-smokers (n(%)) 244 51.3% 301 63.5% 47 60.3%
Pack-years 21.7 ±19.2 20.2 ±16.8 21.2 ±19.6
Smokers (n(%)) 76 16.0% 57 12.0% 13 16.7%
Pack-years 29.7 ±24.3 25.7 ±20.7 26.2 ±26.7
Time since first Exposure (y) 34.3 ±8.6 39.5 ±9.2 38.5 ±9.8
Age at first Exposure (y) 26.3 ±9.0 24.6 ±7.9 26.3 ±8.3
Duration of Exposure (y) 22.8 ±9.0 25.1 ±9.4 23.4 ±9.6
Cumulative Exposure (y.f/ml) 88.9 ±92.4 137.0 140.8 143.3 ±135.4
Mean Exposure (f/L) 3.9 ±3.4 5.5 ±5.1 6.5 ±5.6
Results are given as means and standard deviations or as numbers and percent, as relevant.
Table 2: Modelling the prevalence of pleural plaques using logistic regression
Model 1 Model 2
OR 95%CI p OR 95%CI p
Time since first exposure (y) 1.075 1.059, 1.092 <0.001 1.067 1.051, 1.083 <0.001
Mean exposure (f/ml) 1.114 1.077, 1.153 <0.001
Cumulative exposure 
(10 y.f/ml)
1.036 1.023, 1.049 <0.001
Akaike Information Criterion 1228.0 1235.4
Model: Log(P/1-P)= -3.22+0.072 TSFE (y) +0.108 mean expo (f/ml) -2.83+0.065 TSFE (y) +0.0035 cum expo (y.f/ml)
OR: Odds Ratio by exposure unit
95%CI: 95% Confidence Intervals
p: p-value of a test of a zero coefficient
P: Prevalence of pleural plaques.Environmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
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ject with a 10 f/ml mean exposure compared with a 2 f/ml
mean exposure is exp(0.069 · (10-2)) = 1.74. The mini-
mum observed latency for a subject with pleural plaques
was 16 years. We can note that the fit of the logistic model
to the data as assessed by the Akaike information crite-
rion, seems to be very close to the complementary log-log
model.
Finally, Table 4 presents the best-fitting logistic models of
the prevalence of asbestosis. Although the coefficients of a
model including time since first exposure and cumulative
exposure are statistically significant, the best fitting model
according to the Akaike information criterion includes age
and mean exposure.
When fitting a complementary log-log regression, some
coefficients were negative, indicating that some hypothe-
ses on which this model is based are not met.
Discussion
Overall, TSFE was the key variable for both pleural
plaques and asbestosis, and duration of exposure was not
found to be predictive, adjusted on TSFE High exposure
concentration to asbestos appears also to be a significant
variable with a less significant than TSFE. Regarding these
results, clinicians should mainly consider these two varia-
bles before including exposed subjects in a CT Scan
screening. According to our modelling of incidence, a use-
ful periodicity of survey of pleural plaques by CT-scan
may range between 5 to 10 years
This population is characterized by an asbestos exposure
assessment based mainly on historical measures and the
systematic use of CT-scan for the diagnosis of asbestos-
related diseases. To our knowledge, it is the first time that
such data are published.
Most of published studies reported a positive dose-
response relationship between prevalence of pleural
plaques and asbestos exposure [1,17]. Time since first
exposure is known to be strongly associated with pleural
plaques in the literature [7]. Jakobsson et al. [18] reported
that time since first exposure was more correlated to prev-
alence of pleural plaques assessed on chest X-rays than
cumulative exposure, after adjustment on age and smok-
ing status. More recently, Koskinen et al. described a prev-
alence of bilateral pleural plaques ranging between 1.2%
(latency < 16 years) to 32.2% (latency > = 40 years) in a
large study of construction, shipyard and asbestos indus-
try workers [3]. In this study, a lesser positive correlation
with the duration of asbestos exposure was also reported.
Erhlich at al. [19] showed in multiple regression analysis
that only time since first exposure was significantly related
to prevalence of pleural plaques, but neither cumulative
exposure nor duration of exposure. Our results however
showed that both mean (or cumulative) exposure and
time since first exposure are determinants for the preva-
Fitted prevalence of pleural plaques according to time since  first exposure and mean asbestos exposure Figure 1
Fitted prevalence of pleural plaques according to time since 
first exposure and mean asbestos exposure.
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Table 3: Modelling the incidence of pleural plaques using a complementary log-log regression
Model 1 Model 2
coefficient 95%CI p coefficient 95%CI p
Intercept Log(k/(α +1)) -5.093 -6.098, -4.089 <0.001 -4.553 -5.519, -3.588 <0.001
Log time since first exposure 1.340 1.045, 1.635 <0.001 1.201 0.913, 1.490 <0.001
Mean exposure (f/ml) 0.069 0.049, 0.090 <0.001
Cumulative exposure (100 y.f/ml) 0.211 0.142, 0.281 <0.001
Akaike Information Criterion 1230.3 1239.4
Fitted Incidence model 0.00823 × (TSFE-10)0.340 × exp(0.069. mean expo) 0.0127 × (TSFE-10)0.201 × exp(0.00211.cum expo)
95%CI: 95% Confidence Intervals
p: p-value of a test of a zero coefficient
TSFE: Time Since First Exposure.Environmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
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lence. This discrepancy may be explained by the better
precision of our exposure data.
Asbestosis is also associated with latency [3] but the main
parameter seems to be cumulative exposure [18-20]. A
threshold was estimated about 25 fibres/ml.years [21]
that confirmed experimental and epidemiological data.
However, some cases were described below this threshold,
mainly in case of very intense exposure [19]. It is generally
recognized that the latency of asbestosis is shorter with
increasing intensity of exposure [22]. Again, we found
that the time since first exposure and cumulative exposure
are independent factors of the prevalence of asbestosis.
According to our results, we propose to define subjects at
high risk of developing asbestos-related diseases on the
basis of time since first exposure and high level of expo-
sure.
The question of the optimal periodicity of CT-scan follow-
ups in asbestos workers remains unsolved. In our study,
no estimates could obtain for the incidence of asbestosis,
but incidence model of pleural plaques shows that the
increase is modest over the years. For example, according
to the model including only time since first exposure and
mean exposure, the yearly incidence increases from 0.8%
10 years after the onset of exposure to 2.4% 30 years after
exposure onset for a mean exposure of 1 fibre/ml. This
finding agrees with the literature, even if only few papers
were published on this topic. In a cohort survey (> 20
years) of insulators, the incidence of pleural plaques was
estimated between 15% to 21% and between 4 to 10% for
parenchymal abnormalities [19]. According to our find-
ings, a useful periodicity of medical survey by CT-scan for
pleural plaques may range between 5 to 10 years (4% to
24% of new cases of pleural plaques accordingly to our
data), that it is less frequent that the recent statement of
the ATS [1].
However, some limits of our study have to be discussed.
First, the population used in this study is not representa-
tive of the general population as only asbestos-exposed
volunteers were included. We included subjects from sev-
eral plants and the participation rates were not assessed
for all of them, reason why we do not perform analyses by
industrial sectors. Moreover, we enrolled only supposed
healthy subjects for the screening results, which entailed a
selection of these subjects. E.g., we can assume that the
most severe cases of asbestosis in these populations were
diagnosed before inclusion on a clinical basis and were
thus not included in the study population. This, as well as
the small number of cases, may probably explain the dif-
ficulties to fit the data and obtain a valid model for the
asbestosis incidence. However, if this selection may influ-
ence the parameter values in the model of estimated prev-
alence for asbestosis in our sample, this selection bias is
probably minor for pleural plaques as this disease is usu-
ally asymptomatic [23].
A second point is the availability of dose exposure assess-
ment and accordingly the usefulness of our results for cli-
nicians. Atmospheric measurements, as in our study, are
rarely available and retrospective assessment of asbestos
exposure is usually based on job-specific questionnaires
and job exposures matrices [24]. None of these two meth-
ods is clearly the better [25]. However, some combina-
tions of the two may provide sufficiently accurate
estimates of asbestos exposure [26] and may be use d in
actual clinical practice.
Another point is the technique of HRCT used in this pro-
gram. We have already discussed in a previous publication
[13] that a 6 slices protocol is considered adequate for the
diagnosis of asbestosis and had been recommended [2].
For pleural plaques, the use of mediastinal windows and
Table 4: Modelling the prevalence of asbestosis using logistic regression
Model 1 Model 2
OR 95%CI p OR 95%CI p
Time since first exposure (y) 1.03 1.00, 1.06 0.038
Mean exposure (f/ml) 1.09 1.04, 1.14 <0.001
Cumulative exposure (10 y.f/ml) 1.03 1.01, 1.04 0.001
Age (y) 1.07 1.03, 1.11 <0.001
Akaike Information Criterion 446.0 427.9
Model: Log(P/1-P)= -4.22+0.031 TSFE(y) +0.0027 cum expo (y.f/ml) -7.55+ 0.088 mean expo (f/ml) +0.068 age(y)
OR: Odds Ratio by exposure unit
95%CI: 95% Confidence Intervals
p: p-value of a test of a zero coefficient
P: Prevalence of asbestosis
TSFE: Time Since First Exposure.Environmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
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a continuous acquisition of data minimized the risk of
missing pleural abnormalities.
Two basically equivalent statistical models were used to
model the prevalence of pleural plaques and asbestosis in
this population. However, fitting this model on these data
allowed us, given some assumptions, to get a mathemati-
cally simple expression for the incidence. The most
important assumption is that the possibility of being
observed (i.e. being included in the population) does not
depend on the presence of pleural plaques, respectively
asbestosis. It has already been discussed that this does not
seem to be a problem for pleural plaques but certainly is
one for asbestosis, hence the inconsistent results for its
interpretation. The second assumption is that the asbestos
exposure does not vary with time for each subject when
the prevalence was assessed. As most workers are retired
and as asbestos is now banned, this does not appear to be
a major issue. The last assumption is that the incidence
curve takes a specific functional form which states that the
incidence is zero until a given minimum latency and
increases as a power function of (time since first exposure
minus minimum latency), multiplied by a basic incidence
depending only on the past asbestos exposure.
Conclusion
Time since first exposure and mean (or cumulative) expo-
sure to asbestos were both independently and signifi-
cantly associated to the prevalence and, to the incidence
of pleural plaques and asbestosis. These two parameters
have to be included in definitions of high risk subjects for
non malignant asbestos related diseases. If the evaluation
of the lung cancer screening procedures by Low-Dose CT-
Scan confirms his effectiveness, it will be necessary to nar-
row the definition of people suitable for such screening
programs. Among existing models of lung cancer predic-
tion, no one included asbestos exposure to our knowl-
edge. Our results indicate that both latency and dose
should be discussed if these prediction models are to con-
sider asbestos exposure. Finally, short-periodicity of sur-
vey of pleural plaques by CT-Scan seemed not to be
warranted.
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Appendix A
Inferring an incidence model based on prevalence data: 
the mathematical model
This derivation follows the mathematical model pro-
posed by Järvholm (1992)
Let us assume that the incidence model has following
mathematical form
I(t) = k.(t-w)α.fβ.dγ  if t>w (1)
The constant k may depend on other characteristics like
smoking or age at first exposure, but is not allowed to
depend on time. The latter condition is not an intrinsic
assumption, but the model cannot be fitted using stand-
ard software unless it is met.
This means in particular that while age cannot be fitted
but the period of birth is allowed.
This has also the consequence that this model may only
be applied assuming that the exposure has ceased at the
time of the disease assessment by TDM.
We postulate the existence of a cohort exposed to asbes-
tos, for which each subject was submitted to a TDM at
some time t since his/her first exposure to asbestos.
We assume further that the fact that this disease assess-
ment was independent of the actual disease status.
Let us further denote by N(t), the number of exposed sub-
jects in this cohort at time t and P(t) the disease preva-
lence (i.e. the prevalence of pleural plaques) at this time.
At time t, N(t)(1-P(t)) subjects do not show pleural
plaques and are therefore at risk of developing pleural
plaques.
In a Δt time span following t, the number of new cases can
be written as N(t).ΔP(t) on one side, and, if Δt is a short
time span, as the Δt.I(t).N(t)(1-P(t)) on the other side.
Thus we have N(t).ΔP(t) = Δt.I(t).N(t)(1-P(t))Environmental Health 2008, 7:30 http://www.ehjournal.net/content/7/1/30
Page 8 of 8
(page number not for citation purposes)
Cancelling out N(t) and dividing both terms by Δt, we get
Letting Δt go to zero and solving the differential equation,
we obtain
Taking the natural logarithm of the opposite, we obtain
following formula
This is the formula for a complementary log-log regres-
sion of the prevalence data which is easily fitted with any
software (e.g. SAS, Stata, GLIM) providing a generalized
linear modelling framework. The independent variables
fitted are, in this case, the logarithms of the exposure var-
iables and the logarithm of the lagged time since first
exposure.
When the fitted independent exposure variables consist in
a single untransformed exposure concentration f, the inci-
dence is
I(t) = k.(t-w)α.exp(βf) if t>w
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